• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卫生经济学家论患者参与建模:潜在获益、危害和关注变量。

Health Economists on Involving Patients in Modeling: Potential Benefits, Harms, and Variables of Interest.

机构信息

Faculty of Pharmaceutical Sciences, University of British Columbia, Room 4103 Pharmaceutical Sciences Building, 2405 Wesbrook Mall, Vancouver, British Columbia, V6T 1Z3, Canada.

Sauder School of Business, University of British Columbia, Henry Angus Building 2053 Main Mall, Vancouver, British Columbia, V6T 1Z2, Canada.

出版信息

Pharmacoeconomics. 2021 Jul;39(7):823-833. doi: 10.1007/s40273-021-01018-5. Epub 2021 May 7.

DOI:10.1007/s40273-021-01018-5
PMID:33959937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8200342/
Abstract

BACKGROUND

Patient involvement in health economics modeling has been advocated on numerous grounds, including as a way to better manage social and ethical value judgments in the modeling process. However, some have pointed to potential risks and variables that could influence the overall benefit of involvement. To inform future research, there is a need to generate knowledge on potential benefits, harms, and variables relevant to patient involvement in health economics modeling.

METHODS

This analysis used data from a qualitative study in which 22 health economists were asked their views on the possibility of involving patients in the modeling process. Using qualitative methods, the authors organized participants' responses into theory-driven categories ("potential benefits", "potential harms", "variables of interest") and identified data-driven themes and subthemes within those categories.

RESULTS

Findings point to potential benefits and harms to the model, modeler, patient, and modeling process. Variables of interest relevant to future research included patients' specific roles, modeler and patient characteristics, the goals of modeling, dynamics among participators, and features of high-level procedures. The findings raise a number of specific questions that may be fruitful to explore in future research on patient involvement in health economics modeling.

摘要

背景

患者参与健康经济学建模有诸多原因,包括在建模过程中更好地管理社会和伦理价值判断。然而,一些人指出了可能影响参与整体收益的潜在风险和变量。为了为未来的研究提供信息,有必要就患者参与健康经济学建模的潜在利益、危害和相关变量生成知识。

方法

本分析使用了一项定性研究的数据,其中 22 名健康经济学家被要求就患者参与建模过程的可能性发表意见。作者使用定性方法,将参与者的回答组织成理论驱动的类别(“潜在利益”、“潜在危害”、“感兴趣的变量”),并在这些类别中确定了数据驱动的主题和子主题。

结果

研究结果表明,患者参与建模对模型、建模者、患者和建模过程都有潜在的利益和危害。未来研究相关的感兴趣变量包括患者的具体角色、建模者和患者的特征、建模的目标、参与者之间的动态以及高级程序的特征。研究结果提出了一些具体的问题,这些问题可能对未来关于患者参与健康经济学建模的研究很有价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01c/8200342/475910eee2fe/40273_2021_1018_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01c/8200342/7d4e0e10eec9/40273_2021_1018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01c/8200342/b8457defa7df/40273_2021_1018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01c/8200342/475910eee2fe/40273_2021_1018_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01c/8200342/7d4e0e10eec9/40273_2021_1018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01c/8200342/b8457defa7df/40273_2021_1018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d01c/8200342/475910eee2fe/40273_2021_1018_Fig3_HTML.jpg

相似文献

1
Health Economists on Involving Patients in Modeling: Potential Benefits, Harms, and Variables of Interest.卫生经济学家论患者参与建模:潜在获益、危害和关注变量。
Pharmacoeconomics. 2021 Jul;39(7):823-833. doi: 10.1007/s40273-021-01018-5. Epub 2021 May 7.
2
'Managing values' in health economics modelling: Philosophical and practical considerations.健康经济学建模中的“管理价值观”:哲学和实践方面的考虑。
Soc Sci Med. 2024 Oct;358:117256. doi: 10.1016/j.socscimed.2024.117256. Epub 2024 Aug 16.
3
Social, ethical, and other value judgments in health economics modelling.健康经济学建模中的社会、伦理和其他价值判断。
Soc Sci Med. 2020 May;253:112975. doi: 10.1016/j.socscimed.2020.112975. Epub 2020 Apr 2.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Research participants' perceptions and views on consent for biobank research: a review of empirical data and ethical analysis.研究参与者对生物样本库研究知情同意的认知与观点:实证数据回顾与伦理分析
BMC Med Ethics. 2015 Sep 9;16:60. doi: 10.1186/s12910-015-0053-5.
6
Involving Members of the Public in Health Economics Research: Insights from Selecting Health States for Valuation to Estimate Quality-Adjusted Life-Year (QALY) Weights.让公众参与健康经济学研究:从选择健康状态进行估值以估算质量调整生命年 (QALY) 权重中获得的见解。
Appl Health Econ Health Policy. 2018 Apr;16(2):187-194. doi: 10.1007/s40258-017-0355-5.
7
Evaluating public involvement in research design and grant development: Using a qualitative document analysis method to analyse an award scheme for researchers.评估公众在研究设计和资助项目制定过程中的参与情况:运用定性文献分析方法对一项面向研究人员的奖励计划进行分析。
Res Involv Engagem. 2016 Apr 1;2:13. doi: 10.1186/s40900-016-0027-x. eCollection 2016.
8
Q methodology in health economics.
J Health Serv Res Policy. 2006 Jan;11(1):38-45. doi: 10.1258/135581906775094217.
9
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.不同种族文化群体成年癌症患者的姑息治疗体验:一项定性系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
10
Patient involvement in a qualitative meta-synthesis: lessons learnt.患者参与定性元综合研究:经验教训
Res Involv Engagem. 2016 May 12;2:18. doi: 10.1186/s40900-016-0032-0. eCollection 2016.

引用本文的文献

1
Mathematical Modelling for Community Based Intervention for Managing Diabetes: A Systematic Literature Review.基于社区干预管理糖尿病的数学建模:一项系统文献综述
J Multidiscip Healthc. 2025 May 1;18:2429-2440. doi: 10.2147/JMDH.S510753. eCollection 2025.
2
Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative: implications for decision making.分析来自国家药物滥用研究所数据共享计划的阿片类药物使用障碍患者的生活质量:对决策的影响。
Qual Life Res. 2024 Oct;33(10):2783-2796. doi: 10.1007/s11136-024-03729-6. Epub 2024 Aug 8.
3
Improving Transparency of Decision Models Through the Application of Decision Analytic Models with Omitted Objects Displayed (DAMWOOD).

本文引用的文献

1
Correction to: Developing a Framework for Public Involvement in Mathematical and Economic Modelling: Bringing New Dynamism to Vaccination Policy Recommendations.对《制定公众参与数学和经济建模的框架:为疫苗接种政策建议注入新活力》的更正
Patient. 2021 Jul;14(4):447. doi: 10.1007/s40271-021-00497-0.
2
Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study.理解和识别临床医生参与决策分析模型结构制定中的关键问题:一项定性研究。
Pharmacoeconomics. 2018 Dec;36(12):1453-1462. doi: 10.1007/s40273-018-0705-7.
3
Saturation in qualitative research: exploring its conceptualization and operationalization.
通过应用显示省略对象的决策分析模型(DAMWOOD)来提高决策模型的透明度。
Pharmacoeconomics. 2024 Nov;42(11):1197-1208. doi: 10.1007/s40273-024-01401-y. Epub 2024 Aug 7.
4
Making Decision Models Fit for Purpose: The Importance of Ensuring Stakeholder Involvement.使决策模型适用于特定目的:确保利益相关者参与的重要性。
Pharmacoeconomics. 2024 Mar;42(3):249-252. doi: 10.1007/s40273-023-01348-6. Epub 2024 Jan 18.
5
Values in Modelling: Video Series Development and Evaluation Survey.建模中的价值:视频系列开发与评估调查
Appl Health Econ Health Policy. 2023 Sep;21(5):813-820. doi: 10.1007/s40258-023-00820-w. Epub 2023 Jul 5.
6
Patient and Public Involvement in Health Economics Modelling Raises the Need for Normative Guidance.患者和公众参与健康经济学建模提出了规范指导的需求。
Pharmacoeconomics. 2023 Jul;41(7):733-740. doi: 10.1007/s40273-023-01274-7. Epub 2023 Apr 27.
7
The public and patient involvement imperative in Ireland: Building on policy drivers.爱尔兰的公众和患者参与强制要求:基于政策驱动因素。
Front Public Health. 2022 Nov 10;10:1038409. doi: 10.3389/fpubh.2022.1038409. eCollection 2022.
8
Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network.开发在线基础设施以提高模型的可及性和验证性:同行模型网络
Pharmacoeconomics. 2022 Oct;40(10):1005-1009. doi: 10.1007/s40273-022-01179-x. Epub 2022 Jul 30.
9
Four Aspects Affecting Health Economic Decision Models and Their Validation.影响健康经济决策模型及其验证的四个方面。
Pharmacoeconomics. 2022 Mar;40(3):241-248. doi: 10.1007/s40273-021-01110-w. Epub 2021 Dec 16.
10
Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling.新冠疫苗接种模型中的价值判断:以需要公众参与以健康为导向的建模为例。
Soc Sci Med. 2021 Oct;286:114323. doi: 10.1016/j.socscimed.2021.114323. Epub 2021 Aug 18.
定性研究中的饱和度:探索其概念化与操作化
Qual Quant. 2018;52(4):1893-1907. doi: 10.1007/s11135-017-0574-8. Epub 2017 Sep 14.
4
The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling.被忽视的利益相关者群体:患者为何应参与卫生经济建模
Appl Health Econ Health Policy. 2016 Apr;14(2):129-33. doi: 10.1007/s40258-015-0200-7.